0001745285-20-000014.txt : 20200617 0001745285-20-000014.hdr.sgml : 20200617 20200617170736 ACCESSION NUMBER: 0001745285-20-000014 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200616 FILED AS OF DATE: 20200617 DATE AS OF CHANGE: 20200617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WIINBERG ULF CENTRAL INDEX KEY: 0001187314 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-29089 FILM NUMBER: 20970441 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AGENUS INC CENTRAL INDEX KEY: 0001098972 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 061562417 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-674-4410 MAIL ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: ANTIGENICS INC /DE/ DATE OF NAME CHANGE: 19991115 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2020-06-16 0 0001098972 AGENUS INC AGEN 0001187314 WIINBERG ULF C/O AGENUS INC. 3 FORBES ROAD LEXINGTON MA 02421 1 0 0 0 Restricted Stock Unit 2020-06-16 4 A 0 16853 0 A 2021-06-16 Common Stock 16853 37191 D Restricted Stock Unit was granted on June 16, 2020 in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The award fully vests on June 16, 2021. Includes 20,338 Restricted Stock Units that are scheduled to vest on June 19, 2020. /s/Evan D. Kearns, as Attorney-in-Fact for Ulf Wiinberg 2020-06-17